Immediate Impact
24 by Nobel laureates 37 from Science/Nature 74 standout
Citing Papers
Gliflozins in the Management of Cardiovascular Disease
2022 Standout
Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
2022 Standout
Works of Stefan Wagner being referenced
Cardioprotection by SGLT2 Inhibitors—Does It All Come Down to Na+?
2021
Empagliflozin Reduces Ca/Calmodulin-Dependent Kinase II Activity in Isolated Ventricular Cardiomyocytes
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Stefan Wagner | 3534 | 3387 | 1066 | 144 | 6.4k | |
| Olli Vuolteenaho | 3831 | 1731 | 1380 | 240 | 7.2k | |
| Ray E. Hershberger | 7747 | 4309 | 1155 | 146 | 11.0k | |
| Jos F.M. Smits | 3424 | 2665 | 958 | 170 | 6.5k | |
| Mark Aronovitz | 2246 | 2077 | 797 | 98 | 5.4k | |
| Jeanette Erdmann | 1963 | 2048 | 632 | 179 | 5.6k | |
| Uta C. Hoppe | 4826 | 1589 | 1150 | 292 | 6.9k | |
| Koichiro Kuwahara | 3043 | 2883 | 970 | 216 | 6.1k | |
| Tsutomu Araki | 1662 | 1077 | 695 | 139 | 4.6k | |
| Christer Sylvén | 2709 | 2117 | 1487 | 246 | 6.8k | |
| E. René Rodríguez | 3810 | 2482 | 2314 | 147 | 8.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...